JPS5953483A - チアゾ−ル誘導体 - Google Patents

チアゾ−ル誘導体

Info

Publication number
JPS5953483A
JPS5953483A JP58150471A JP15047183A JPS5953483A JP S5953483 A JPS5953483 A JP S5953483A JP 58150471 A JP58150471 A JP 58150471A JP 15047183 A JP15047183 A JP 15047183A JP S5953483 A JPS5953483 A JP S5953483A
Authority
JP
Japan
Prior art keywords
group
formula
compound
compounds
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58150471A
Other languages
English (en)
Japanese (ja)
Inventor
バリ−・クライブ・ロス
ジエフリ−・ダニエル・マイクル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Hoechst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst UK Ltd filed Critical Hoechst UK Ltd
Publication of JPS5953483A publication Critical patent/JPS5953483A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP58150471A 1982-08-20 1983-08-19 チアゾ−ル誘導体 Pending JPS5953483A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8224024 1982-08-20
GB8224024 1982-08-20

Publications (1)

Publication Number Publication Date
JPS5953483A true JPS5953483A (ja) 1984-03-28

Family

ID=10532436

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58150471A Pending JPS5953483A (ja) 1982-08-20 1983-08-19 チアゾ−ル誘導体

Country Status (11)

Country Link
US (1) US4649145A (enExample)
EP (1) EP0102026A3 (enExample)
JP (1) JPS5953483A (enExample)
KR (1) KR840005723A (enExample)
AU (1) AU1816883A (enExample)
DK (1) DK382283A (enExample)
ES (2) ES8502438A1 (enExample)
GB (1) GB2125404B (enExample)
GR (1) GR79384B (enExample)
PT (1) PT77221B (enExample)
ZA (1) ZA836129B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010535180A (ja) * 2007-08-01 2010-11-18 ユニヴェルシテ ドゥ レンヌ １ イミダゾロン誘導体、その調製方法およびその生物学的使用
JP2022082098A (ja) * 2020-11-20 2022-06-01 三菱電機株式会社 電源装置

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585781A (en) * 1982-12-31 1986-04-29 Glaxo Group Limited Heterocyclic derivatives
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
JPH01156965A (ja) * 1987-09-29 1989-06-20 Taiho Yakuhin Kogyo Kk チオヒダントイン化合物
GB9611046D0 (en) * 1996-05-25 1996-07-31 Wivenhoe Techn Ltd Pharmacological compounds
WO2002053155A1 (en) * 2000-12-30 2002-07-11 Geron Corporation Telomerase inhibitor
KR101404185B1 (ko) * 2012-03-09 2014-06-11 연세대학교 산학협력단 Ｗｎｔ／β-카테닌 신호전달계와 관련된 질병의 예방 및 치료용 약학 조성물
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB2001624B (en) * 1977-04-20 1982-03-03 Ici Ltd Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
US4374836A (en) * 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
EP0014057B1 (en) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
IL61233A (en) * 1979-10-24 1984-08-31 Smith Kline French Lab Guanidino thiazolylalkylamino(alkylthioalkylamino)nitro pyrroles,process for their preparation and pharmaceutical compositions containing them
GR71929B (enExample) * 1979-11-13 1983-08-19 Ici Ltd

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010535180A (ja) * 2007-08-01 2010-11-18 ユニヴェルシテ ドゥ レンヌ １ イミダゾロン誘導体、その調製方法およびその生物学的使用
JP2022082098A (ja) * 2020-11-20 2022-06-01 三菱電機株式会社 電源装置

Also Published As

Publication number Publication date
ES527237A0 (es) 1985-04-16
GB2125404A (en) 1984-03-07
PT77221B (en) 1986-03-18
EP0102026A2 (en) 1984-03-07
PT77221A (en) 1983-09-01
DK382283A (da) 1984-02-21
ES525007A0 (es) 1985-01-01
GB8322359D0 (en) 1983-09-21
GR79384B (enExample) 1984-10-22
DK382283D0 (da) 1983-08-19
KR840005723A (ko) 1984-11-16
ES8502438A1 (es) 1985-01-01
AU1816883A (en) 1984-02-23
ZA836129B (en) 1984-04-25
GB2125404B (en) 1985-11-13
US4649145A (en) 1987-03-10
ES8504790A1 (es) 1985-04-16
EP0102026A3 (en) 1984-05-16

Similar Documents

Publication Publication Date Title
EP1666480B1 (en) Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents.
AU654808B2 (en) Diaromatic substituted anti-aids compounds
US4666908A (en) 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use
US4873346A (en) Substituted benzothiazoles, benzimidazoles, and benzoxazoles
JP6308504B2 (ja) タンパク質キナーゼ阻害薬
CS200545B2 (en) Method of producing derivatives of guanidine
KR100292592B1 (ko) 세로토닌길항제로서의n-시아노n'-피리딜구아니딘
MXPA05005406A (es) Compuestos quimicos novedosos.
JPH07502742A (ja) Ｐａｆ−レセプタ拮抗剤としてのアミノ酸誘導体
JPH02243689A (ja) ピラゾロピリジン化合物およびその製造法
KR880001291A (ko) 세로토닌 길항물질의 치료학적 사용방법
CA2191979A1 (en) Condensed imidazole compounds, their production and use
PT98673B (pt) Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios
DE4408497A1 (de) Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JPH0327370A (ja) チアゾール化合物、その製造法およびそれを含有する医薬組成物
DE69130362T2 (de) Imidazopyridinderivate, verfahren zu deren herstellung und deren anwendung
JPS60156671A (ja) ジヒドロピリジン誘導体およびその製造法
DE69226703T2 (de) Imidazo (4,5-c)pyridinderivate als paf antagonisten
PT93979B (pt) Processo para a preparacao de guanidinas heterociclicas
EP0102026A2 (en) Thiazole derivatives
EP0579646B1 (en) Anti-cancer antracene derivatives
US3953493A (en) Substituted sulfonamide derivatives as anthelmintic agents
US3770766A (en) 2-(2-amino-2,2-dialkylamino-3-hydroxy-3-phenyl-1h-benz(f)isoindole-1-ones
JPS6112662A (ja) ジヒドロピリジン誘導体及びその製法
WO1994003439A1 (en) Antiproliferative tricyclic compounds